Atypical femur fractures (AFFs) have been reported with long term use of anti-resorptive drugs. Early identification is crucial because it allows early intervention to stop the progression to complete fracture, thus potentially reducing the ensuing burden. It has been shown that extending the scan image to take a full-length image of the femur (FFI) using single energy (SE) X-rays at the time of a dual-energy X-ray absorptiometry (DXA) scan can detect findings in the spectrum of AFF. Following the International Society for Clinical Densitometry (ISCD) recommendations, FFI by SE X-ray is being performed for all patients who present to the Calcium Metabolism and Osteoporosis program at AUBMC for BMD measurement by DXA, if they have received anti-resorptive drug for, a cumulative period of 3 years or more. Patients can be currently on anti-resorptive drug or have discontinued it within the past 5 years prior to scan, instead of the 1 year, as recommended by the ISCD. The primary aim of this retrospective study was to assess the prevalence of findings in the spectrum of AFF using FFI by SE X-rays. We collected data on demographic factors, clinical risk factors for osteoporosis, and bone densitometry parameters. Out of the 948 patients, 18 patients were found to have findings in the spectrum of AFF, 14 underwent subsequent imaging studies to investigate and confirm these abnormalities. One patient out of 948 patients was found to have an incomplete AFF confirmed by CT scan. Studying the prevalence of the signs of AFF on FFI in other studies and assessing the specificity of this technique by comparing its findings to more established methods, is important. Future ISCD task forces may need to re-assess efficacy and cost effectiveness of its recommended guidance on using SE femur in patients to prevent adverse outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jbmr/zjae174 | DOI Listing |
Plant Mol Biol
December 2024
State Key Laboratory of Crop Genetics & Germplasm Enhancement and Utilization, Zhongshan Biological Breeding laboratoryr, Nanjing Agricultural University, Nanjing, 210095, China.
Microbiome
December 2024
MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Orphanet J Rare Dis
December 2024
Department of Neurology, The First Affiliated Hospital, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Sun Yat-Sen University, No. 58 Zhongshan Road 2, Guangzhou, 510080, China.
Background: Neuromyelitis Optica Spectrum Disorders (NMOSD) comprise a group of autoimmune-mediated, inflammatory, demyelinating central nervous system diseases caused by aquaporin-4 (AQP4) IgG autoantibodies. Efgartigimod is a human IgG Fc fragment that reduces antibody titers by targeting the neonatal Fc receptor (FcRn). This study documents the efficacy of efgartigimod combined with intravenous methylprednisolone (IVMP) in the acute phase of NMOSD.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
December 2024
Department of Obstetrics and Gynecology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China.
Background: Placenta accreta spectrum (PAS) is one of the most dangerous pregnancy-related conditions. This study aims to conduct a systematic review of current research on the ultrasound scoring systems used in PAS patients with a comprehensive summarization of researches and comparison of prenatal ultrasound scoring in evaluating postpartum outcomes.
Methods: This systematic review was conducted and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
World Neurosurg
December 2024
Department of Neurosurgery, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Yamanashi, Japan.
Objective: Malignant glioma progresses rapidly and shows poor prognosis, but clinically applicable blood plasma-based biochemical tumor markers remain lacking. This study aimed to develop a diagnostic system using probe electrospray ionization mass spectrometry (PESI-MS) and a machine-learning logistic regression model to detect plasma changes at various time points in a murine glioma model.
Methods: We used a syngeneic intracranial orthotopic murine model with GL261 glioma cells.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!